$36.11
1.04% yesterday
Nasdaq, Nov 25, 09:47 pm CET
ISIN
US04963C2098
Symbol
ATRC

AtriCure, Inc. Stock price

$36.01
+8.08 28.93% 1M
+12.82 55.28% 6M
+0.32 0.90% YTD
-5.99 14.26% 1Y
-40.71 53.06% 3Y
+6.16 20.64% 5Y
+17.47 94.23% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.28 0.77%
ISIN
US04963C2098
Symbol
ATRC
Sector

Key metrics

Market capitalization $1.76b
Enterprise Value $1.70b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.80
P/S ratio (TTM) P/S ratio 3.92
P/B ratio (TTM) P/B ratio 3.77
Revenue growth (TTM) Revenue growth 17.56%
Revenue (TTM) Revenue $447.57m
EBIT (operating result TTM) EBIT $-34.16m
Free Cash Flow (TTM) Free Cash Flow $-1.15m
Cash position $130.34m
EPS (TTM) EPS $-0.83
P/E forward negative
P/S forward 3.81
EV/Sales forward 3.69
Short interest 4.76%
Show more

Is AtriCure, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

AtriCure, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a AtriCure, Inc. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a AtriCure, Inc. forecast:

Buy
100%

Financial data from AtriCure, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
448 448
18% 18%
100%
- Direct Costs 116 116
21% 21%
26%
332 332
16% 16%
74%
- Selling and Administrative Expenses 267 267
15% 15%
60%
- Research and Development Expense 81 81
20% 20%
18%
-16 -16
18% 18%
-4%
- Depreciation and Amortization 18 18
34% 34%
4%
EBIT (Operating Income) EBIT -34 -34
25% 25%
-8%
Net Profit -39 -39
57% 57%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about AtriCure, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AtriCure, Inc. Stock News

Neutral
Business Wire
6 days ago
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Piper Sandler 36th Annual Healthcare Conference. AtriCure's management is scheduled to participate i...
Neutral
Business Wire
19 days ago
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Stifel 2024 Healthcare Conference. AtriCure's management is scheduled to participate in a fireside c...
Neutral
Seeking Alpha
27 days ago
AtriCure, Inc. (NASDAQ:ATRC ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief Executive Officer Angela Wirick - Chief Financial Officer Conference Call Participants Lilia Lozada - JPMorgan Mike Matson - Needham Danielle Antalffy - UBS Suraj Kalia - Oppenheimer & Co. Operator Good afternoon. ...
More AtriCure, Inc. News

Company Profile

AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.

Head office United States
CEO Michael Carrel
Employees 1,200
Founded 1994
Website www.atricure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today